Cited 0 times in Scipus Cited Count

Low-level expression of necroptosis factors indicates a poor prognosis of the squamous cell carcinoma subtype of non-small-cell lung cancer

DC Field Value Language
dc.contributor.authorLim, JH-
dc.contributor.authorOh, S-
dc.contributor.authorKim, L-
dc.contributor.authorSuh, YJ-
dc.contributor.authorHa, YJ-
dc.contributor.authorKim, JS-
dc.contributor.authorKim, HJ-
dc.contributor.authorPark, MH-
dc.contributor.authorKim, YS-
dc.contributor.authorCho, Y-
dc.contributor.authorKwak, SM-
dc.contributor.authorLee, HL-
dc.contributor.authorKim, YS-
dc.contributor.authorRyu, JS-
dc.date.accessioned2022-12-16T05:44:36Z-
dc.date.available2022-12-16T05:44:36Z-
dc.date.issued2021-
dc.identifier.issn2218-6751-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/23369-
dc.description.abstractBackground: The programmed cell death pathway necroptosis may synergize with the DNA damage response (DDR) in opposing tumor progression. While our basic mechanistic understanding of the necroptotic cell death advances rapidly, its prognostic implications have not been thoroughly examined in cancers. Methods: We included 394 patients with stage I non-small-cell lung cancer (NSCLC) who underwent surgical tumor resection between 1 January 1997 and 31 December 2011 and measured expression levels of nine proteins involved in necroptosis and the DDR in primary samples from 394 patients using tissue microarray. Protein expression evaluated by using an H-score method was dichotomized by the median value. The overall survival as the endpoint was calculated from the time of diagnosis to the time of the last follow-up or death. Results: We find that low-level expression of the necroptosis markers RIPK3 and PELI1 is associated with high risk of patient death. High-level expression of the key DDR factor p53 in combination with low-level expression of either RIPK3 or PELI1 increases the risk further. These gene expression effects appear to occur specifically in the squamous cell carcinoma (SCC) subtype of stage I NSCLC, while not observed in the non-SCC subtypes. Conclusions: Low-level expression of such necroptosis factors as RIPK3 and PELI1 in combination with high-level expression of the DDR factor p53 can serve as a critical indicator in predicting survival of stage I NSCLC patients with the SCC subtype.-
dc.language.isoen-
dc.titleLow-level expression of necroptosis factors indicates a poor prognosis of the squamous cell carcinoma subtype of non-small-cell lung cancer-
dc.typeArticle-
dc.identifier.pmid33889504-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044481/-
dc.subject.keywordDNA damage response (DDR)-
dc.subject.keywordNecroptosis-
dc.subject.keywordNon-small-cell lung cancer (NSCLC)-
dc.subject.keywordSquamous cell carcinoma (SCC)-
dc.subject.keywordSurvival-
dc.contributor.affiliatedAuthorKim, JS-
dc.type.localJournal Papers-
dc.identifier.doi10.21037/tlcr-20-1027-
dc.citation.titleTranslational lung cancer research-
dc.citation.volume10-
dc.citation.number3-
dc.citation.date2021-
dc.citation.startPage1221-
dc.citation.endPage1230-
dc.identifier.bibliographicCitationTranslational lung cancer research, 10(3). : 1221-1230, 2021-
dc.identifier.eissn2226-4477-
dc.relation.journalidJ022186751-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Biochemistry & Molecular Biology
Files in This Item:
33889504.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse